SCHEMBL20140431

SCHEMBL20140431

CC(C)(C)C(CNC(=O)O)n1ncc(-c2ccccc2)c1CO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.36
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
PTGIR P43119 2/20 0.34
MAPT P10636 5/20 0.34
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
NFKB1 P19838 2/20 0.34
NFKB2 Q00653 2/20 0.34
RELA Q04206 2/20 0.34
LPAR1 Q92633 1/20 0.34
CNR2 P34972 2/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GPR119 Q8TDV5 1/20 0.33
HPGD P15428 1/20 0.33
STAT1 P42224 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20140448 0.91 PTGIR (0.38) SMN1; SMN2KDM5AKDM4CKDM5BPTGIR
SCHEMBL25731618 0.65 CYP11B2 (0.47) SMN1; SMN2PTGIRMAPTNPC1RAB9A
SCHEMBL20140432 0.65 CKS1B (0.45) SMN1; SMN2PTGIR
SCHEMBL20140430 0.63 PTGIR (0.43) SMN1; SMN2PTGIRMAPTNPC1RAB9A
SCHEMBL21247485 0.61 CNR1 (0.43) SMN1; SMN2MAPTNPC1RAB9ACNR2
SCHEMBL27996913 0.61 PTGIR (0.49) SMN1; SMN2PTGIRMAPTNPC1RAB9A
SCHEMBL9877332 0.61 MAPT (0.54) SMN1; SMN2PTGIRMAPTNPC1RAB9A
SCHEMBL9877609 0.59 SMN1; SMN2 (0.51) SMN1; SMN2PTGIRMAPTNPC1RAB9A
SCHEMBL23401005 0.58 RAB9A (0.39) SMN1; SMN2PTGIRMAPTNPC1RAB9A
SCHEMBL27996599 0.58 LPAR1 (0.64) SMN1; SMN2PTGIRLPAR1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089493-A1 PYRROLE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed